P

Pheon Therapeutics

10 employees

Pheon Therapeutics is an Antibody-Drug Conjugate (ADC) specialist that creates ADCs for a variety of difficult-to-treat cancers.

Basic info

Industry

biotechnology research

Sectors

Biotechnology
Life Science
Therapeutics
Medical

Date founded

2022

Funding rounds raised

Total raised

$68M

from 5 investors over 5 rounds

P

Pheon Therapeutics raised $68M on September 28, 2022

Investors: Research Corporation Technologies, Inc., Forbion, Atlas Venture and Brandon Capital Partners

P

Pheon Therapeutics raised undisclosed on January 1, 2022

Investors: Research Corporation Technologies, Inc.

FAQ